<div>1. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death.<i>Circulation</i> . 2012;125(4):620-637.
doi:10.1161/CIRCULATIONAHA.111.023838</div><div>2. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant
ventricular arrhythmias with an implanted automatic defibrillator in
human beings. <i>N Engl J Med</i> . 1980;303(6):322-324.
doi:10.1056/NEJM198008073030607</div><div>3. Woods B, Hawkins N, Mealing S, et al. Individual patient data network
meta-analysis of mortality effects of implantable cardiac devices.<i>Heart Br Card Soc</i> . 2015;101(22):1800-1806.
doi:10.1136/heartjnl-2015-307634</div><div>4. Gold MR, Higgins S, Klein R, et al. Efficacy and temporal stability
of reduced safety margins for ventricular defibrillation: primary
results from the Low Energy Safety Study (LESS). <i>Circulation</i> .
2002;105(17):2043-2048. doi:10.1161/01.cir.0000015508.59749.f5</div><div>5. Neuzner J, Pitschner HF, Huth C, Schlepper M. Effect of biphasic
waveform pulse on endocardial defibrillation efficacy in humans.<i>Pacing Clin Electrophysiol PACE</i> . 1994;17(2):207-212.
doi:10.1111/j.1540-8159.1994.tb01373.x</div><div>6. Brignole M, Occhetta E, Bongiorni MG, et al. Clinical evaluation of
defibrillation testing in an unselected population of 2,120 consecutive
patients undergoing first implantable cardioverter-defibrillator
implant. <i>J Am Coll Cardiol</i> . 2012;60(11):981-987.
doi:10.1016/j.jacc.2012.05.014</div><div>7. Borne RT, Randolph T, Wang Y, et al. Analysis of Temporal Trends and
Variation in the Use of Defibrillation Testing in Contemporary Practice.<i>JAMA Netw Open</i> . 2019;2(10):e1913553.
doi:10.1001/jamanetworkopen.2019.13553</div><div>8. Olsovsky MR, Shorofsky SR, Gold MR. Effect of shock polarity on
biphasic defibrillation thresholds using an active pectoral lead system.<i>J Cardiovasc Electrophysiol</i> . 1998;9(4):350-354.
doi:10.1111/j.1540-8167.1998.tb00923.x</div><div>9. Denman RA, Umesan C, Martin PT, et al. Benefit of millisecond
waveform durations for patients with high defibrillation thresholds.<i>Heart Rhythm</i> . 2006;3(5):536-541. doi:10.1016/j.hrthm.2006.01.027</div><div>10. Dopp AL, Miller JM, Tisdale JE. Effect of drugs on defibrillation
capacity. <i>Drugs</i> . 2008;68(5):607-630.
doi:10.2165/00003495-200868050-00004</div><div>11. Bollmann A, Husser D, Cannom DS. Antiarrhythmic drugs in patients
with implantable cardioverter-defibrillators. <i>Am J Cardiovasc
Drugs Drugs Devices Interv</i> . 2005;5(6):371-378.
doi:10.2165/00129784-200505060-00004</div><div>12. Kroll MW, Schwab JO. Achieving low defibrillation thresholds at
implant: pharmacological influences, RV coil polarity and position, SVC
coil usage and positioning, pulse width settings, and the azygous vein.<i>Fundam Clin Pharmacol</i> . 2010;24(5):561-573.
doi:10.1111/j.1472-8206.2010.00848.x</div><div>13. Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR. Comparison
of single- and dual-coil active pectoral defibrillation lead systems.<i>J Am Coll Cardiol</i> . 1998;31(6):1391-1394.
doi:10.1016/s0735-1097(98)00103-x</div><div>14. Faheem O, Padala A, Kluger J, Zweibel S, Clyne CA. Coronary sinus
shocking lead as salvage in patients with advanced CHF and high
defibrillation thresholds. <i>Pacing Clin Electrophysiol PACE</i> .
2010;33(8):967-972. doi:10.1111/j.1540-8159.2010.02726.x</div><div>15. Kühlkamp V, Dörnberger V, Mewis C, Seipel L. Comparison of the
efficacy of a subcutaneous array electrode with a subcutaneous patch
electrode, a prospective randomized study. <i>Int J Cardiol</i> .
2001;78(3):247-256. doi:10.1016/s0167-5273(01)00381-3</div>